UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028674
Receipt number R000032403
Scientific Title A clinical study for TBP-101 (CHDF hemofilter)
Date of disclosure of the study information 2017/08/15
Last modified on 2018/08/16 10:47:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A clinical study for TBP-101 (CHDF hemofilter)

Acronym

A clinical study for TBP-101 (CHDF hemofilter)

Scientific Title

A clinical study for TBP-101 (CHDF hemofilter)

Scientific Title:Acronym

A clinical study for TBP-101 (CHDF hemofilter)

Region

Japan


Condition

Condition

Acute Kidney Injury

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the clinical performance and safety of TBP-101 by conducting CHDF to patients diagnosed with acute kidney injury.

Basic objectives2

Others

Basic objectives -Others

Safety/Clinical Performance

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1)Average hours the investigational device is used
2)Adverse events
3)Device deficiencies

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Perform CRRT by using TBP-101 for 24 hours or more per device.Use 3 investigational devices per patient.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1)Patients who are 20 and over, and under 80.
2)Patients diagnosed with acute kidney injury by using KDIGO definition within 2 days before the first consent.

Key exclusion criteria

1)Patients with disease hard to be treated by CRRT, such as Heparin-Induced Thrombocytopenia (HIT).

2)Patients with anamnesis of allergy symptoms such as anaphylaxis caused by dialyzer, hemofilter et al.

Target sample size

14


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Chihiro Ishizuka

Organization

Toray Industries,Inc.

Division name

Clinical Data Science & Quality Management Dept.

Zip code


Address

1-1, Nihonbashi-muromachi 2-chome, Chuo-ku,Tokyo

TEL

03-3245-8588

Email

Chihiro_Ishizuka@nts.toray.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Chihiro Ishizuka

Organization

Toray Industries, Inc.

Division name

Clinical Data Science & Quality Management Dept.

Zip code


Address

1-1, Nihonbashi-muromachi 2-chome, Chuo-ku,Tokyo

TEL

03-3245-8588

Homepage URL


Email

Chihiro_Ishizuka@nts.toray.co.jp


Sponsor or person

Institute

Toray Industries,Inc.

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 05 Month 11 Day

Date of IRB


Anticipated trial start date

2017 Year 07 Month 25 Day

Last follow-up date

2018 Year 05 Month 27 Day

Date of closure to data entry

2018 Year 07 Month 30 Day

Date trial data considered complete

2018 Year 07 Month 31 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 08 Month 15 Day

Last modified on

2018 Year 08 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032403


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name